DarioHealth Corp.

NASDAQ: DRIO · Real-Time Price · USD
0.72
0.02 (2.86%)
At close: May 30, 2025, 3:58 PM
0.68
-4.73%
After-hours: May 30, 2025, 05:06 PM EDT

Company Description

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand.

The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems.

It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching.

The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016.

DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DarioHealth Corp.
DarioHealth Corp. logo
Country United States
IPO Date Mar 14, 2016
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 196
CEO Erez Raphael

Contact Details

Address:
18 West 18th Street
New York, New York
United States
Website https://www.mydario.com

Stock Details

Ticker Symbol DRIO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001533998
CUSIP Number 23725P209
ISIN Number US23725P2092
Employer ID 45-2973162
SIC Code 3841

Key Executives

Name Position
Erez Raphael Chief Executive Officer & Director
Limor Drezner Chief People Officer
Tomer Ben-Kiki Chief Technology Officer
Zvi Ben David CPA Chief Financial Officer, Treasurer & Secretary
Claudia Levi Content & Communications Manager
Dov Oppenheim Co-Founder & Production Chief
Kat Parrella Investor Relations Manager
Lara Dodo Chief Operations Officer
Mona Dean Chief Compliance Officer
Steven C. Nelson Chief Commercial Officer

Latest SEC Filings

Date Type Title
May 29, 2025 8-K Current Report
May 28, 2025 S-3 Filing
May 21, 2025 8-K Current Report
May 20, 2025 PRE 14A Filing
May 15, 2025 4 Filing
May 15, 2025 3 Filing
May 14, 2025 10-Q Quarterly Report
May 13, 2025 SCHEDULE 13G/A [Amend] Filing
May 06, 2025 8-K Current Report
Apr 28, 2025 8-K Current Report